King Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Sep 08 |
Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
|
|---|---|---|---|---|---|
| Net Operating Cash Flow | 111.7 | 138.0 | 100.2 | 245.6 | 174.3 |
| Net Investing Cash Flow | 24.4 | 132.2 | 707.0 | (250.6) | (205.7) |
| Net Financing Cash Flow | (0.2) | (1.2) | (0.6) | 0.1 | 1.6 |
| Net Change in Cash | 135.9 | 269.0 | 806.6 | (4.9) | (29.8) |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Capital Expenditures | (12.6) | (13.0) | (19.9) | (12.9) | (18.6) |
| Cash Dividends Paid | -- | -- | -- | -- | -- |
This data is provided as per license from EDGAR Online
